18.80 USD
↘ 0.31 (1.62%)AT CLOSE (11:59 AM EDT)
Apollomics Inc. Class A Ordinary Shares
APLMNASDAQ • USD
18.80
↘ 0.01 (0.03%)
POST MARKET (AS OF 04:11 PM EDT)
Post Market
AS OF 04:11 PM EDT
18.80
↘ 0.01 (0.03%)
Market: CLOSED
Apollomics Inc. Class A Ordinary Shares (APLM) is currently trading at $18.45. Technical indicators currently signal "Buy". Notable factors include a bullish Golden Cross on the moving averages.
Technical & fundamental data as of Jul 9, 2026.
Open?$19.10
High?$19.10
Low?$18.73
Prev. Close?$19.11
Volume?1.8K
Avg. Volume?N/A
VWAP?$18.83
Bid / Ask
Bid?$12.75 × 200
Ask?$20.00 × 100
Spread?$7.25
Midpoint?$16.38
Valuation & Ratios
Market Cap?42.0M
Shares Out?2.2M
Float?789.1K
Float %?36.8%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
Apollomics Inc is an clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company programs include vebreltinib (APL-101), selective c-Met inhibitor for the treatment of non-small cell lung cancer and other tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia. Company has three new immuno-oncology product candidates: APL-501, APL-502 and APL-801 include mono-specific and bi-specific antibodies to fight against cancer.
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental Outlook
Loading...
Short InterestLow
Short % of Float?0.32%Low
Short Interest?2.5K
Days to Cover?1.0
Free Float789.1K
Avg Daily Volume10.0K
Settlement Date2026-06-15